The Ca(2+) Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal

Ca(2+) channel blockers (CCBs) are commonly used to treat different cardiovascular conditions. These drugs disrupt the intracellular Ca(2+) signaling network, inhibiting numerous cellular functions in different cells, including T lymphocytes. We explored the effect of the CCB verapamil on normal hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Veytia-Bucheli, José Ignacio, Alvarado-Velázquez, Den Alejandro, Possani, Lourival Domingos, González-Amaro, Roberto, Rosenstein, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324055/
https://www.ncbi.nlm.nih.gov/pubmed/35890372
http://dx.doi.org/10.3390/pharmaceutics14071478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324055/
https://www.ncbi.nlm.nih.gov/pubmed/35890372
http://dx.doi.org/10.3390/pharmaceutics14071478

Ejemplares similares